Thomas S. Lam - Dec 15, 2023 Form 4 Insider Report for Apollo Medical Holdings, Inc. (AMEH)

Role
President and Co-CEO, Director
Signature
/s/ Thomas S. Lam
Stock symbol
AMEH
Transactions as of
Dec 15, 2023
Transactions value $
$0
Form type
4
Date filed
12/18/2023, 04:35 PM
Previous filing
Dec 7, 2022
Next filing
Sep 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMEH Common Stock Award $0 +30K +10.28% $0.00 322K Dec 15, 2023 Direct F2
transaction AMEH Common Stock Award $0 +30K +9.32% $0.00 352K Dec 15, 2023 Direct F3
transaction AMEH Common Stock Award $0 +30K +8.53% $0.00 382K Dec 15, 2023 Direct F4, F5
holding AMEH Common Stock 1.11M Dec 15, 2023 By the Thomas and Jeanette Lam 2002 Family Trust
holding AMEH Common Stock 7.13M Dec 15, 2023 By Allied Physicians of California, a Professional Medical Corporation F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are beneficially owned by Allied Physicians of California, a Professional Medical Corporation, of which the Reporting Person is a director, officer and shareholder. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F2 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors.
F3 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of a pre-established performance goal, the shares of restricted stock shall vest in four equal annual installments, beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors.
F4 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of a pre-established performance goal, the shares of restricted stock shall, based on the date the performance goal is achieved, vest either (i) in four equal annual installments, beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors or (ii) three annual installments of 15,000, 7,500 and 7,500, respectively, beginning on a date during the first quarter of 2026 to be determined by the compensation committee.
F5 Includes 111,748 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 21,748 shares, which will vest on November 2, 2024; (ii) 30,000 shares, which will vest in four equal annual installments beginning in the first quarter of 2025; (iii) 30,000 shares, which will vest upon achievement of certain pre-established performance goals; and (iv) 30,000 shares, which will vest upon achievement of certain pre-established performance goals.